PubRank

Gad Rennert

Author PubWeight™ 133.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Statins and the risk of colorectal cancer. N Engl J Med 2005 6.86
2 Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 2008 6.75
3 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010 4.96
4 Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007 4.69
5 RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007 3.63
6 Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008 3.41
7 Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2002 3.25
8 Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 2010 3.18
9 Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst 2008 2.78
10 Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet 2013 2.39
11 Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet 2011 2.35
12 Genetic variation in 8q24 associated with risk of colorectal cancer. Cancer Biol Ther 2007 2.32
13 A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet 2002 2.24
14 Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2009 2.13
15 Vitamin D status in primary hyperparathyroidism. Eur J Intern Med 2011 2.05
16 Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs. Genet Epidemiol 2008 2.04
17 BLM heterozygosity and the risk of colorectal cancer. Science 2002 2.03
18 Clinical phenotype of families with longevity. J Am Geriatr Soc 2004 2.03
19 Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol 2003 1.97
20 Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 2010 1.90
21 Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 2013 1.88
22 Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat 2008 1.76
23 BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst 2004 1.76
24 The relationship between serum 25(OH)D and parathyroid hormone levels. Am J Med 2011 1.70
25 MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers. Cancer Res 2011 1.68
26 Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet 2010 1.56
27 Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 2005 1.48
28 Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer. Cancer Prev Res (Phila) 2010 1.45
29 Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. CMAJ 2011 1.38
30 Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer. Cancer Epidemiol Biomarkers Prev 2010 1.31
31 The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nat Genet 2004 1.25
32 Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol 2009 1.23
33 FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations. Cancer Epidemiol Biomarkers Prev 2008 1.22
34 The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev 2008 1.22
35 Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol 2013 1.20
36 Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. Am J Pathol 2003 1.20
37 Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim. Am J Hum Genet 2003 1.16
38 Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. Clin Cancer Res 2009 1.15
39 BRCA germline mutations in Jewish women with uterine serous papillary carcinoma. Gynecol Oncol 2004 1.14
40 Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol 2011 1.12
41 Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer 2012 1.07
42 Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients. Cancer 2011 1.03
43 Gene expression differences between colon and rectum tumors. Clin Cancer Res 2011 1.03
44 The effect of statins on risk and survival of gynecological malignancies. Gynecol Oncol 2013 1.03
45 Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res 2006 1.01
46 Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control 2010 0.98
47 K-ras mutations in sporadic colorectal tumors in Israel: unusual high frequency of codon 13 mutations and evidence for nonhomogeneous representation of mutation subtypes. Dig Dis Sci 2002 0.97
48 Vascular disorders preceding diagnosis of cancer: distinguishing the causal relationship based on Bradford-Hill guidelines. Angiology 2003 0.95
49 The risk of all-cause mortality is inversely related to serum 25(OH)D levels. J Clin Endocrinol Metab 2012 0.94
50 CDX2 polymorphisms, RNA expression, and risk of colorectal cancer. Cancer Res 2005 0.91
51 BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst 2015 0.90
52 Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine 2015 0.90
53 Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). Cancer Causes Control 2011 0.89
54 Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2014 0.89
55 RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2006 0.88
56 Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2007 0.88
57 Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible? J Natl Cancer Inst 2005 0.88
58 FOXP3 germline polymorphisms are not associated with risk of breast cancer. Cancer Genet Cytogenet 2009 0.87
59 Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet 2011 0.87
60 The association between obesity and urinary tract infection. Eur J Intern Med 2012 0.86
61 Clustering women's health behaviors. Health Educ Behav 2002 0.86
62 Excellent performance of Hemoccult Sensa in organised colorectal cancer screening. Eur J Cancer 2012 0.86
63 The longitudinal variability of serum 25(OH)D levels. Eur J Intern Med 2012 0.85
64 Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use. Cancer 2010 0.85
65 Calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche. Am J Clin Nutr 2003 0.84
66 Quality control in a National Program for the Early Detection of Breast Cancer: women's satisfaction with the mammography process. Womens Health Issues 2008 0.84
67 Low integrated DNA repair score and lung cancer risk. Cancer Prev Res (Phila) 2013 0.83
68 The use of exercise stress testing for the management of low-risk patients with chest pain. Am J Emerg Med 2009 0.83
69 N-methylpurine DNA glycosylase and OGG1 DNA repair activities: opposite associations with lung cancer risk. J Natl Cancer Inst 2012 0.83
70 Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer. PLoS One 2013 0.82
71 High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation. Gastroenterology 2011 0.81
72 Dietary intake of carotenoid isomers in Israel. Int J Vitam Nutr Res 2007 0.81
73 International collaborations in cancer control and the Third International Cancer Control Congress. Tumori 2009 0.81
74 Maternal mosaicism for a second mutational event--a novel deletion--in a familial adenomatous polyposis family harboring a new germ-line mutation in the alternatively spliced-exon 9 region of APC. Hum Mutat 2002 0.81
75 Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patients. Dis Colon Rectum 2005 0.81
76 BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews. Cancer Epidemiol Biomarkers Prev 2009 0.80
77 APC E1317Q is not associated with Colorectal Cancer in a population-based case-control study in Northern Israel. Cancer Epidemiol Biomarkers Prev 2006 0.80
78 Sustained effect of short-term calcium supplementation on bone mass in adolescent girls with low calcium intake. Am J Clin Nutr 2005 0.80
79 Recreational physical activity modifies the association between a common GH1 polymorphism and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2008 0.80
80 Vitamin D Status in Israeli subjects before the initiation and after the cessation of vitamin D supplements. Calcif Tissue Int 2011 0.79
81 Common MUTYH mutations and colorectal cancer risk in multiethnic populations. Fam Cancer 2012 0.78
82 PTPRJ haplotypes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2008 0.78
83 Unraveling seasonality in population averages: an examination of seasonal variation in glucose levels in diabetes patients using a large population-based data set. Chronobiol Int 2011 0.78
84 Fecal occult blood test performance indicators in warfarin-treated patients. Dis Colon Rectum 2010 0.78
85 The evaluation of vitamin D status in normocalcemic primary hyperparathyroidism. Eur J Intern Med 2012 0.78
86 Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations. Eur J Cancer Prev 2009 0.78
87 The rationale for delaying aging and the prevention of age-related diseases. Rambam Maimonides Med J 2012 0.78
88 Self-rated health is prospectively associated with uptake of screening for the early detection of colorectal cancer, not vice versa. Eur J Cancer Prev 2016 0.78
89 APC I1307K and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006 0.77
90 Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation. Am J Obstet Gynecol 2008 0.77
91 Statins, aspirin and risk of venous thromboembolic events in breast cancer patients. J Thromb Thrombolysis 2014 0.76
92 Corrigendum: Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun 2015 0.76
93 BRCA2 germline mutation in a woman with uterine serous papillary carcinoma--case report. Gynecol Oncol 2005 0.76
94 Bisphosphonates: beyond prevention of bone metastases. J Natl Cancer Inst 2011 0.75
95 Are we getting closer to molecular population screening for colorectal cancer? J Natl Cancer Inst 2009 0.75
96 Inference of the haplotype effect in a matched case-control study using unphased genotype data. Int J Biostat 2008 0.75
97 Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers. J Natl Cancer Inst 2017 0.75
98 BRCA1/2 mutation carriers: living with susceptibility. Community Genet 2003 0.75
99 Evaluation of chest pain in the ED: factors affecting triage decisions. Am J Emerg Med 2003 0.75
100 Obesity and association of serum 25(OH)D levels with all-cause mortality. Calcif Tissue Int 2014 0.75
101 Cancer prevention: from public health interventions to individual tailoring. Eur J Cancer Prev 2007 0.75
102 Ethnic differences in the epidemiological characteristics of severe trauma due to falls from heights among children in northern Israel. Isr Med Assoc J 2007 0.75
103 Antithrombotic therapy for prevention of stroke in clinical practice in the ED. Am J Emerg Med 2007 0.75